Cargando…
Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
Autores principales: | Honore, Patrick M., Barreto Gutierrez, Leonel, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545152/ https://www.ncbi.nlm.nih.gov/pubmed/33036639 http://dx.doi.org/10.1186/s13054-020-03294-7 |
Ejemplares similares
-
Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
por: Honore, Patrick M., et al.
Publicado: (2020) -
Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
por: Honore, Patrick M., et al.
Publicado: (2020) -
Irrespective of the degree of hyperlactatemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with non-users: beware of confounders!
por: Honore, Patrick M., et al.
Publicado: (2020) -
Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
por: Honore, Patrick M., et al.
Publicado: (2020) -
SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
por: Honore, Patrick M., et al.
Publicado: (2020)